XML 76 R45.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2024
Segment Information  
Schedule of reportable segment information

December 31

December 31

    

2024

    

2023

Revenue

$

56,294

$

68,184

Less:

Cost of revenue

4,685

6,923

Research and development (1)

4,709

5,674

Sales

5,895

7,777

Sales operations

2,946

3,702

General and administration

12,651

14,208

Depreciation and amortization

283

292

Other segment expenses (2)

4,192

7,352

Segment operating profit

20,933

22,256

Interest income, net

1,877

2,471

Impairment of investments

(337)

Change in fair value of notes held for investment

128

(307)

Change in fair value of digital assets

24,933

Other corporate income (3)

13

17

Income before taxes

47,884

24,100

Income tax expense

6,985

3,517

Net income

$

40,899

$

20,583

(1)Research and development include clinical affairs and HITRUST.
(2)Other segment expenses include marketing, customer education, business development, and strategic streamlining.
(3)Other corporate income represents unallocated income.